The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A. H., Wewer, U. M., & Nielsen, F. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1262 · Cited by 721
Hansen, T. V. O., Hammer, N. A., Nielsen, J., Madsen, M., Dalbaeck, C., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4448-4464.2004 · Cited by 251
Cited by
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
“…that is overexpressed in a variety of human cancers, including those of the breast, lung and colon, where it potentially plays a role in stabilizing several target mRNAs, including c-myc, b-catenin and b-TrCP1 (Ross et al., 1997; Doyle et al., 1998; Nielsen et al., 1999; Noubissi et al., 2006).”
Bell, J. L., Wächter, K., Mühleck, B., Pazaitis, N., Köhn, M., Lederer, M., & Hüttelmaier, S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1186-z · Cited by 783
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
MicroRNA regulation by RNA-binding proteins and its implications for cancer
van Kouwenhove, M., Kedde, M., & Agami, R. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3107 · Cited by 617
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma, B., & Hottiger, M. O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00378 · Cited by 563
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Wang, Y., Lu, J.-H., Wu, Q.-N., Jin, Y., Wang, D.-S., Chen, Y.-X., Liu, J., Luo, X.-J., Meng, Q., Pu, H.-Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1105-0 · Cited by 507
Self-citationTranscriptional plasticity promotes primary and acquired resistance to BET inhibition
Rathert, P., Roth, M., Neumann, T., Muerdter, F., Roe, J.-S., Muhar, M., Deswal, S., Cerny-Reiterer, S., Peter, B., Jude, J., et al. (2015) · Nature · doi:10.1038/nature14898 · Cited by 499
Xu, J., Chen, Y., & Olopade, O. I. (2010) · Genes & Cancer · doi:10.1177/1947601910378691 · Cited by 382
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
Müller, S., Glaß, M., Singh, A. K., Haase, J., Bley, N., Fuchs, T., Lederer, M., Dahl, A., Huang, H., Chen, J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1012 · Cited by 379
Vallée, A., & Lecarpentier, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00745 · Cited by 374
Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development · doi:10.1101/gad.287540.116 · Cited by 324
“Nevertheless, there is evidence to suggest that IMP1 expression is subject to regulation by the Wnt pathway (Noubissi et al. 2006; Gu et al. 2008; Nishino et al. 2013).”
BackgroundControl of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs
Weidensdorfer, D., Stöhr, N., Baude, A., Lederer, M., Köhn, M., Schierhorn, A., Buchmeier, S., Wahle, E., & Hüttelmaier, S. (2009) · RNA · doi:10.1261/rna.1175909 · Cited by 318
SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation
Westbrook, T. F., Hu, G., Ang, X. L., Mulligan, P., Pavlova, N. N., Liang, A., Leng, Y., Maehr, R., Shi, Y., Harper, J. W., et al. (2008) · Nature · doi:10.1038/nature06780 · Cited by 311
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Kugel, S., Sebastián, C., Fitamant, J., Ross, K. N., Saha, S. K., Jain, E., Gladden, A., Arora, K. S., Kato, Y., Rivera, M. N., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.033 · Cited by 294
APC and Its Modifiers in Colon Cancer
Kwong, L. N., & Dove, W. F. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1145-2_8 · Cited by 254
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
MicroRNAs in the etiology of colorectal cancer: Pathways and clinical implications
Strubberg, A. M., & Madison, B. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027441 · Cited by 147
The Structural Basis for RNA Selectivity by the IMP Family of RNA-Binding Proteins
Biswas, J., Patel, V. L., Bhaskar, V., Chao, J. A., Singer, R. H., & Eliscovich, C. (2019) · Nature Communications · doi:10.1038/s41467-019-12193-7 · Cited by 84
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
Elcheva, I. A., Gowda, C. P., Bogush, D., Gornostaeva, S., Fakhardo, A., Sheth, N., Kokolus, K. M., Sharma, A., Dovat, S., Uzun, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224516 · Cited by 66
“…a physiological signi fi cance of SCF b - TrCP1 E3 ubiquitin ligase ’ s protein substrates, b -catenin and the inhibitor of NF-kB (IKKb), for colon and melanoma cancer progression as high levels of human IGF2BP1 in these cancers were associated with NF-kB-activated antiapoptotic programs (40, 42).”
BackgroundSelf-citationLoss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon
Hamilton, K. E., Chatterji, P., Lundsmith, E. T., Andres, S. F., Giroux, V., Hicks, P. D., Noubissi, F. K., Spiegelman, V. S., & Rustgi, A. K. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0224 · Cited by 52
Self-citationDuan, H., Cherradi, N., Feige, J.-J., & Jefcoate, C. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0296 · Cited by 42
Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1
Chatterji, P., Williams, P. A., Whelan, K. A., Samper, F. C., Andres, S. F., Simon, L. A., Parham, L. R., Mizuno, R., Lundsmith, E. T., Lee, D. S., et al. (2019) · The EMBO Reports · doi:10.15252/embr.201847074 · Cited by 32
Waly, A. A., El-Ekiaby, N., Assal, R. A., Abdelrahman, M. M., Hosny, K. A., El Tayebi, H. M., Esmat, G., Breuhahn, K., & Abdelaziz, A. I. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01918 · Cited by 23
“However, an IGF2BP-induced stabilization of mRNAs has been described for IGF2BP-1 which was reported to protect BTRC, C-MYC, and CD44 against miRs and the degradation machinery (Noubissi et al., 2006; Vikesaa et al., 2006; Elcheva et al., 2009).”
Background
Metadata
- Authors
- Noubissi, F. K., Elcheva, I., Bhatia, N., Shakoori, A., Ougolkov, A., Liu, J., Minamoto, T., Ross, J., Fuchs, S. Y., & Spiegelman, V. S.
- Venue
- Nature
- Published
- 2006-06
- Volume
- 441
- Issue
- 7095
- Pages
- 898-901
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1491870867
- Cited by
- 243
- References
- 2
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.